Authorizing The Special Committee on Kensington to convene for the purpose of investigating and addressing the barriers to accessing treatment beds in the Kensington area.

Authorizing The Special Committee on Kensington to convene for the purpose of investigating and addressing the barriers to accessing treatment beds in the Kensington area. WHEREAS, Individuals in the Kensington area are increasingly using Xylazine, a dangerous drug known to cause severe harm, including eating away at human flesh when snorted or injected, and treatment centers are not adequately equipped to handle the unique challenges presented by individuals using Xylazine, further limiting access to appropriate care; and WHEREAS, Additionally, Xylazine induces severe withdrawal symptoms and poses a risk of mortality, instilling significant fear in individuals seeking treatment. An NPR article sheds light on the multitude of symptoms linked to Xylazine use. One woman vividly recounts, "It literally just ate the front layer of skin on my leg. It just killed the skin," illustrating the severity of its effects. Long wait times, limited beds, and inadequately equipped facilities exacerbate the deterrents for individuals seeking treatment; and WHEREAS, Limited bed availability further compounds the obstacles for individuals seeking treatment. This shortage is particularly daunting for couples or families struggling with addiction, as they may hesitate to seek treatment due to the fear of being separated from each other. NPR Philadelphia provides further evidence of this, reporting that outreach workers have encountered individuals who have been forcibly separated from their loved…